R&D Performance

CKD BiO’s fashionable R&D from fermentation to synthesis shall be continued.

2024

IND approval of phase 3 clinical trial(Glabella Lines) for CKDB-501A by NMPA(China)

2023

Grand prize of 2023 Korea Excellent Patent Award by Hankook Ilbo

2023

Patent grant of US 11642318 (Composition comprising lactic acid bacteria improved in intestinal adherence by coating with silk fibroin)

2023

Completion of phase 3 clinical trial(Glabella Lines) for CKDB-501A

2022

IND approval of phase 1 clinical trial(Upper Limb Spasticity) for CKDB-501A by Ministry of Food and Drug Safety

2022

IND approval of phase 1 clinical trial(Glabella Lines) for CKDB-501A by Ministry of Food and Drug Safety

2021

Approval of Functional Ingredients for Lactobacillus plantarum Q180 by Ministry of Food and Drug Safety

2021

Recipient of Commendation From Minister of Trade, Industry and Energy for Contribution to 「중견기업 핵심연구인력 성장지원사업」

2021

KDMF registration of Peramivir hydrate

2020

Patent grant of KR 102077838 (Novel preparation method of peramivir trihydrate and water system drying method thereof)

2019

Patent grant of KR 101981790 (Composition comprising lactic acid bacteria improved in intestinal adherence by coating with silk fibroin)

2018

Patent grant of KR 101818086 (Streptomyces hygroscopicus Mutant Strain with Increased Productivity of Rapamycin)

2018

KDMF registration of Diquafosol sodium

2017

KDMF registration of Tenofovir disoproxil fumarate

2017

Patent grant of KR 101716879 (Method Producing Daptomycin Using Decanoyl Glyceride)

2016

Developed manufacturing technology for Probiotics / Daptomycin (Antibiotic)

2015

Developed manufacturing technology for Everolimus

2014

Developed manufacturing technology for Rapamycin(Immunosuppressant)

2011

Developed manufacturing technology for Vancomycin(Antibiotic)

2010

Developed manufacturing technology for Caspofungin(Antifungal)
Designated as "Advanced Technology Center"(Ministry of Knowledge Economy, Korea)

2008

Developed manufacturing technology for Mycophenolate Mofetil(Immunosuppressant)

2005

Developed manufacturing technology for Sibutramine Malate(Medicine for weight loss)

2003

Developed manufacturing technology for Tacrolimus(Immunosuppressant)

2002

Developed manufacturing technology for Teicoplanin(Antibiotic)

2000

Developed mass production process for 7-ACA via bioconversion method

1999

Developed synthesis technology for Simvastatin(Antihyperlipidemic)
Developed diagnostic kit for Helicobacter pylori

1997

Developed manufacturing technology for Lovastatin(Antihyperlipidemic)

1994

Developed manufacturing technology for Cyclosporine(Immunosuppressant)

1993

Developed manufacturing technology for 7-ACA(Antibiotic)

1989

Developed synthesis technology for Omeprazole(Medicine for stomach ulcer)

1987

Developed synthesis technology for Cefpiramide(Antibiotic)

1984

Developed manufacturing technology for Bacampicillin(Antibiotic)

1980

Developed manufacturing technology for Rifampicin(Antituberculous)

1974

Developed manufacturing technology for Tetracycline & Oxytetracycline(Antibiotic)